Aardvark Therapeutics Inc (AARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | |
| Cash Flows From Operating Activities | |
| Net Income | -13,564 |
| Depreciation Amortization | 110 |
| Other Working Capital | -1,311 |
| Other Operating Activity | 4,222 |
| Operating Cash Flow | $-10,543 |
| Cash Flows From Investing Activities | |
| Other Investing Activity | -1,000 |
| Investing Cash Flow | $-1,000 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 225 |
| Financing Cash Flow | $225 |
| Beginning Cash Position | 26,877 |
| End Cash Position | 15,559 |
| Net Cash Flow | $-11,318 |
| Free Cash Flow | |
| Operating Cash Flow | -10,543 |
| Free Cash Flow | -10,543 |